Importantly, this decision applied only to the obesity indicationtirzepatide remains available in its anti-diabetic medication (ADM) formulation (sold as Mounjaro) for patients with type 2 diabetes
If more than 34 days have passed since your scheduled injection and you're approaching your next dose day, skip the missed dose entirely and resume your normal weekly schedule
Wegovy pills have now been approved by the MHRA in the UK and the Food and Drug Administration (FDA) in the US, based on clinical trial data from hundreds of adults who are overweight or living with obesity
Risks of GLP-1 for type 1 diabetes include nausea, vomiting, diarrhea, reduced appetite, dehydration, and possible hypoglycemia if insulin doses are not adjusted appropriately
A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression